Literature DB >> 17008681

Extensively drug resistant tuberculosis: beware patients lost to follow-up.

Ulf R Dahle.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 17008681      PMCID： PMC1584338          DOI： 10.1136/bmj.333.7570.705

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  2 in total

1.  Extensively drug resistant tuberculosis.

Authors:  Stephen D Lawn; Robert Wilkinson
Journal:  BMJ       Date:  2006-09-16

2.  Deciphering an outbreak of drug-resistant Mycobacterium tuberculosis.

Authors:  Ulf R Dahle; Per Sandven; Einar Heldal; Turid Mannsaaker; Dominique A Caugant
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948
  2 in total
  9 in total

Review 1.  The emergence of extensively drug-resistant tuberculosis: a global health crisis requiring new interventions: part I: the origins and nature of the problem.

Authors:  Jerrold J Ellner
Journal:  Clin Transl Sci       Date:  2008-12       Impact factor: 4.689

2.  The emergence of extensively drug-resistant tuberculosis (TB): TB/HIV coinfection, multidrug-resistant TB and the resulting public health threat from extensively drug-resistant TB, globally and in Canada.

Authors:  Paul E Alexander; Prithwish De
Journal:  Can J Infect Dis Med Microbiol       Date:  2007-09       Impact factor: 2.471

3.  Efficacy of quinoxaline-2-carboxylate 1,4-di-N-oxide derivatives in experimental tuberculosis.

Authors:  Esther Vicente; Raquel Villar; Asunción Burguete; Beatriz Solano; Silvia Pérez-Silanes; Ignacio Aldana; Joseph A Maddry; Anne J Lenaerts; Scott G Franzblau; Sang-Hyun Cho; Antonio Monge; Robert C Goldman
Journal:  Antimicrob Agents Chemother       Date:  2008-07-14       Impact factor: 5.191

4.  In vitro and in vivo antimycobacterial activities of ketone and amide derivatives of quinoxaline 1,4-di-N-oxide.

Authors:  Raquel Villar; Esther Vicente; Beatriz Solano; Silvia Pérez-Silanes; Ignacio Aldana; Joseph A Maddry; Anne J Lenaerts; Scott G Franzblau; Sang-Hyun Cho; Antonio Monge; Robert C Goldman
Journal:  J Antimicrob Chemother       Date:  2008-05-23       Impact factor: 5.790

5.  Clonal expansion of multidrug-resistant and extensively drug-resistant tuberculosis, Japan.

Authors:  Yoshiro Murase; Shinji Maeda; Hiroyuki Yamada; Akihiro Ohkado; Kinuyo Chikamatsu; Kazue Mizuno; Seiya Kato; Satoshi Mitarai
Journal:  Emerg Infect Dis       Date:  2010-06       Impact factor: 6.883

6.  Synthesis, biological evaluation and 2D-QSAR study of halophenyl bis-hydrazones as antimicrobial and antitubercular agents.

Authors:  Hatem A Abdel-Aziz; Wagdy M Eldehna; Mohamed Fares; Sara T A Al-Rashood; Khalid A Al-Rashood; Marwa M Abdel-Aziz; Dalia H Soliman
Journal:  Int J Mol Sci       Date:  2015-04-20       Impact factor: 5.923

7.  New Conjugates of Quinoxaline as Potent Antitubercular and Antibacterial Agents.

Authors:  Ramalingam Peraman; Rajendran Kuppusamy; Sunil Kumar Killi; Y Padmanabha Reddy
Journal:  Int J Med Chem       Date:  2016-03-08

8.  Initial second-line drug resistance of Mycobacterium tuberculosis isolates from Sudanese retreatment-patients.

Authors:  Muatsim Ahmed Mohammed Adam; Hamdan Mustafa Hamdan Ali; Eltahir Awad Gasim Khalil
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2017-10-26

9.  Extensively drug-resistant tuberculosis (XDR-TB) - a potential threat in Ireland.

Authors:  Anne Marie Mc Laughlin; Rory A O'Donnell; Noel Gibbons; Mary Scully; Darina O'Flangan; Joseph Keane
Journal:  Open Respir Med J       Date:  2007-12-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.